Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for 2011 (376 publications)

no pagination
Dees EC, Infante JR, Cohen RB, O'Neil BH, Jones S, von Mehren M, Danaee H, Lee Y, Ecsedy J, Manfredi M, Galvin K, Stringer B, Liu H, Eton O, Fingert H, Burris H. Phase 1 study of MLN8054, a selective inhibitor of Aurora A kinase in patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 2011 Apr;67(4):945-54.   PMCID: PMC3026871
Dees EC, Infante JR, Cohen RB, O'Neil BH, Jones S, von Mehren M, Danaee H, Lee Y, Ecsedy J, Manfredi M, Galvin K, Stringer B, Liu H, Eton O, Fingert H, Burris H. Phase 1 study of MLN8054, a selective inhibitor of Aurora A kinase in patients with advanced solid tumors. Cancer Chemother Pharmacol. 2011 Apr;67(4):945-54.   PMCID: PMC3026871
De la Mota-Peynado A, Chernoff J, Beeser A. Identification of the Atypical MAPK Erk3 as a Novel Substrate for p21-activated Kinase (Pak) Activity. Journal of Biological Chemistry. 2011 Apr;286(15):13603-11.   PMCID: PMC3075705
del Monte G, Casanova JC, Guadix JA, MacGrogan D, Burch JB, Perez-Pomares JM, de la Pompa JL. Differential Notch Signaling in the Epicardium Is Required for Cardiac Inflow Development and Coronary Vessel Morphogenesis. Circulation research. 2011 Apr;108(7):824-U137.   PMCID: *
Denlinger CS, Engstrom PF. Colorectal cancer survivorship: movement matters. Cancer prevention research (Philadelphia, Pa). 2011 Apr;4(4):502-11.   PMCID: PMC3110682
Frank AK, Pietsch EC, Dumont P, Tao J, Murphy ME. Wild-type and mutant p53 proteins interact with mitochondrial caspase-3. Cancer Biology & Therapy. 2011 Apr;11(8):740-5.   PMCID: PMC3100564
Giralt SA, Mangan KF, Maziarz RT, Bubalo JS, Beveridge R, Hurd DD, Mendoza FL, Rubenstein EB, DeGroot TJ, Schuster MW. Three palonosetron regimens to prevent CINV in myeloma patients receiving multiple-day high-dose melphalan and hematopoietic stem cell transplantation. Annals of Oncology. 2011 Apr;22(4):939-46.   PMCID: not NIH funded
Golemis EA, Serebriiskii I, Finley R L Jr Hunt By Interaction Mating, Kolonin Hunt By Interaction Mating MG, Gyuris J, Brent R. Interaction Trap/Two-Hybrid System to Identify Interacting Proteins. Curr Protoc Neurosci. 2011 Apr;Chapter 4:Unit4 4.   PMCID: not NIH funded
Ilson DH, Kelsen D, Shah M, Schwartz G, Levine DA, Boyd J, Capanu M, Miron B, Klimstra D. A Phase 2 Trial of Erlotinib in Patients With Previously Treated Squamous Cell and Adenocarcinoma of the Esophagus. Cancer. 2011 Apr;117(7):1409-14.   PMCID: PMC3116987
Kappes DJ. Developing intestinal fortitude. Nature immunology. 2011 Apr;12(4):281-2.   PMCID: not NIH funded
Kennedy AL, Morton JP, Manoharan I, Nelson DM, Jamieson NB, Pawlikowski JS, McBryan T, Doyle B, McKay C, Oien KA, Enders GH, Zhang RG, Sansom OJ, Adams PD. Activation of the PIK3CA/AKT Pathway Suppresses Senescence Induced by an Activated RAS Oncogene to Promote Tumorigenesis. Mol Cell. 2011 Apr;42(1):36-49.
Kotova E, Lodhi N, Jarnik M, Pinnola AD, Ji YB, Tulin AV. Drosophila histone H2A variant (H2Av) controls poly(ADP-ribose) polymerase 1 (PARP1) activation in chromatin. Proceedings of the National Academy of Sciences of the United States of America. 2011 Apr;108(15):6205-10.   PMCID: PMC3076809
Kutikov A, Piotrowski ZJ, Canter DJ, Li T, Chen DY, Viterbo R, Greenberg RE, Boorjian SA, Uzzo RG. Routine adrenalectomy is unnecessary during surgery for large and/or upper pole renal tumors when the adrenal gland is radiographically normal. J Urol. 2011 Apr;185(4):1198-203.   PMCID: PMC3117661
Ruder EH, Hartman TJ, Rovine MJ, Dorgan JF. Birth characteristics and female sex hormone concentrations during adolescence: results from the Dietary Intervention Study in Children. Cancer Causes & Control. 2011 Apr;22(4):611-21.   PMCID: PMC311521
Stairs DB, Bayne LJ, Rhoades B, Vega ME, Waldron TJ, Kalabis J, Klein-Szanto A, Lee JS, Katz JP, Diehl JA, Reynolds AB, Vonderheide RH, Rustgi AK. Deletion of p120-Catenin Results in a Tumor Microenvironment with Inflammation and Cancer that Establishes It as a Tumor Suppressor Gene. Cancer Cell. 2011 Apr;19(4):470-83.   PMCID: PMC3077713
Swaby RF, Cristofanilli M. Circulating tumor cells in breast cancer: A tool whose time has come of age. BMC Medicine. 2011 Apr;9:43.   PMCID: PMC3107794
von Mehren M. New therapies in soft tissue and bone sarcomas. Clin Adv Hematol Oncol. 2011 Apr;9(4):319-21.   PMCID: not NIH funded
Wargon V, Fernandez SV, Goin M, Giulianelli S, Russo J, Lanari C. Hypermethylation of the progesterone receptor A in constitutive antiprogestin-resistant mouse mammary carcinomas. Breast Cancer Research and Treatment. 2011 Apr;126(2):319-32.   PMCID: not NIH funded
Reddy S, Shaller CC, Doss M, Shchaveleva I, Marks JD, Yu JQ, Robinson MK. Evaluation of the Anti-HER2 C6.5 Diabody as a PET Radiotracer to Monitor HER2 status and Predict Response to Trastuzumab Treatment. Clinical Cancer Research. 2011 Mar 15;17(6):1509-20.   PMCID: PMC3060271
Rudnick SI, Lou J, Shaller CC, Tang Y, Klein-Szanto AJ, Weiner LM, Marks JD, Adams GP. Influence of Affinity and Antigen Internalization on the Uptake and Penetration of Anti-HER2 Antibodies in Solid Tumors. Cancer Res. 2011 Mar 15;71(6):2250-9.   PMCID: PMC3077882
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications for the year 2011


Last updated on Monday, December 04, 2017